Meechan DW, Tucker ES, Maynard TM, Lamantia A-S. Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome. Proc Natl Acad Sci USA 106: 16434-16445

Department of Cell and Molecular Physiology and Neuroscience Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
Proceedings of the National Academy of Sciences (Impact Factor: 9.67). 09/2009; 106(38):16434-45. DOI: 10.1073/pnas.0905696106
Source: PubMed


The 22q11 deletion (or DiGeorge) syndrome (22q11DS), the result of a 1.5- to 3-megabase hemizygous deletion on human chromosome 22, results in dramatically increased susceptibility for "diseases of cortical connectivity" thought to arise during development, including schizophrenia and autism. We show that diminished dosage of the genes deleted in the 1.5-megabase 22q11 minimal critical deleted region in a mouse model of 22q11DS specifically compromises neurogenesis and subsequent differentiation in the cerebral cortex. Proliferation of basal, but not apical, progenitors is disrupted, and subsequently, the frequency of layer 2/3, but not layer 5/6, projection neurons is altered. This change is paralleled by aberrant distribution of parvalbumin-labeled interneurons in upper and lower cortical layers. Deletion of Tbx1 or Prodh (22q11 genes independently associated with 22q11DS phenotypes) does not similarly disrupt basal progenitors. However, expression analysis implicates additional 22q11 genes that are selectively expressed in cortical precursors. Thus, diminished 22q11 gene dosage disrupts cortical neurogenesis and interneuron migration. Such developmental disruption may alter cortical circuitry and establish vulnerability for developmental disorders, including schizophrenia and autism.

Download full-text


Available from: Eric S Tucker, Jun 17, 2014
  • Source
    • "These findings reveal that abnormal microglial activity, due either to their prenatal absence or activation, perturbs the precise localization of Lhx6-expressing neocortical interneurons both embryonically and postnatally. Since defective interneuron migration and distribution have been also observed in mouse models of neurodevelopmental disorders (Meechan et al., 2009, 2012), microglia dysfunction and genetic predisposition factors may converge onto common targets. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Dysfunction of microglia, the tissue macrophages of the brain, has been associated with the etiology of several neuropsychiatric disorders. Consistently, microglia have been shown to regulate neurogenesis and synaptic maturation at perinatal and postnatal stages. However, microglia invade the brain during mid-embryogenesis and thus could play an earlier prenatal role. Here, we show that embryonic microglia, which display a transiently uneven distribution, regulate the wiring of forebrain circuits. Using multiple mouse models, including cell-depletion approaches and cx3cr1(-/-), CR3(-/-), and DAP12(-/-) mutants, we find that perturbing microglial activity affects the outgrowth of dopaminergic axons in the forebrain and the laminar positioning of subsets of neocortical interneurons. Since defects in both dopamine innervation and cortical networks have been linked to neuropsychiatric diseases, our study provides insights into how microglial dysfunction can impact forebrain connectivity and reveals roles for immune cells during normal assembly of brain circuits.
    Cell Reports 09/2014; 8(5). DOI:10.1016/j.celrep.2014.07.042 · 8.36 Impact Factor
  • Source
    • "suggesting axonal damage or disorganization (Song et al., 2003; Budde et al., 2009). Neuropathological (Kiehl et al., 2009) and animal (Meechan et al., 2009) studies suggest that 22q11.2DS is a disorder of early neuronal migration. It has been demonstrated that neuronal migration may influence axonal placement via its mediation of axonal guidance cues (Lopez-Bendito et al., 2006), suggesting that white matter microstructural anomalies may be due to early neurodevelopmental disruptions. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: The 22q11.2 deletion syndrome (22q11.2DS) is regarded as an etiologically homogenous model for understanding neuroanatomic disruptions associated with a high risk for schizophrenia. This study utilized diffusion tensor imaging (DTI) to analyze white matter microstructure in individuals with 22q11.2DS. We focused on the cingulum bundle (CB), previously shown to be disrupted in patients with schizophrenia and associated with symptoms of psychosis. Methods: White matter microstructure was assessed in the anterior, superior, and posterior CB using the tractography algorithm in DTIStudio. Neuropsychological function, presence of prodromal symptoms of psychosis, and medication history were assessed in all participants. Results: Relative to controls, young adults with 22q11.2DS showed alterations in most DTI metrics of the CB. Alterations were associated with positive prodromal symptoms of psychosis. However, when individuals with 22q11.2DS were divided by usage of antipsychotics/mood stabilizers, the medicated and non-medicated groups differed significantly in axial diffusivity of the anterior CB and in fractional anisotropy of the superior CB. DTI metrics did not differ between the medicated group and the control group. Conclusions: Results suggest that the microstructure of the CB is altered in individuals with 22q11.2DS, and that those alterations may underlie positive prodromal symptoms of psychosis. Our findings further provide preliminary evidence that antipsychotic/mood stabilizer usage may have a reparative effect on white matter microstructure in prodromal 22q11.2DS, independent of the potential effects of psychosis. Future studies of white matter pathology in individuals with 22q11.2DS should test for potential effects of medication on white matter microstructure.
    Schizophrenia Research 07/2014; 161(1). DOI:10.1016/j.schres.2014.07.010 · 3.92 Impact Factor
  • Source
    • "We investigated whether a substantial number of 22q11 genes are expressed in embryonic structures that contribute to the palate, upper jaw and lower jaw (Fig. 3, top). We screened 21 candidates from the deleted region based on previous assessments of expression in the embryo and developing brain (Maynard et al., 2003; Meechan et al., 2009; Maynard et al., 2013). Using quantitative RT-PCR analysis (qPCR) in microdissected samples of maxillary process/branchial arch (BA1A; Fig. 3, top) or a combined mandibular/hyoid sample (BA1B/BA2; Fig. 3, middle top) consisting of the mandibular process (BA1B) and the hyoid process (BA2), we found 16/28 (BA1A) and 19/28 (BA1B/BA2) 22q11 genes expressed in the craniofacial primordia. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We assessed feeding-related developmental anomalies in the LgDel mouse model of Chromosome 22q11 Deletion Syndrome (22q11DS), a common developmental disorder that frequently includes perinatal dysphagia - debilitating feeding, swallowing and nutrition difficulties from birth onward - within its phenotypic spectrum. LgDel pups gain significantly less weight during the first postnatal weeks, and have several signs of respiratory infections due to food aspiration. Most 22q11 genes are expressed in anlagen of craniofacial and brainstem regions critical for feeding and swallowing, and diminished expression in LgDel embryos apparently compromises development of these regions. Palate and jaw anomalies indicate divergent oro-facial morphogenesis. Altered expression and patterning of hindbrain transcriptional regulators, especially those related to retinoic acid (RA) signaling prefigures these disruptions. Subsequently, gene expression, axon growth and sensory ganglion formation in the trigeminal (V), glossopharyngeal (IX), or vagus (X) cranial nerves (CN) that innervate targets essential for feeding, swallowing and digestion are disrupted. Posterior CN IX and X ganglia anomalies primarily reflect diminished dosage of the 22q11DS candidate gene Tbx1. Genetic modification of RA signaling in LgDel embryos rescues the anterior CN V phenotype and returns expression levels or pattern of RA-sensitive genes to that in wild type embryos. Thus, diminished 22q11 gene dosage, including but not limited to Tbx1, disrupts oro-facial and cranial nerve development by modifying RA-modulated anterior-posterior hindbrain differentiation. These disruptions likely contribute to dysphagia in infants and young children with 22q11DS.
    Disease Models and Mechanisms 12/2013; 7(2). DOI:10.1242/dmm.012484 · 4.97 Impact Factor
Show more